Inventor
HUSFELD CRAIG
US71 patents
⚠️ This page may combine multiple inventors who share the name “HUSFELD CRAIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
32 patentsUS7288657B2Oct 30, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC71 citations99
US7265133B2Sep 4, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC65 citations98
US7141671B2Nov 28, 2006
Biphenyl derivatives
THERAVANCE INC145 citations98
US8053448B2Nov 8, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations96
US8034946B2Oct 11, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC28 citations96
US8017783B2Sep 13, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC17 citations96
US7910608B2Mar 22, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations96
US7803812B2Sep 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC19 citations96
US7585879B2Sep 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC35 citations96
US7550595B2Jun 23, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7524965B2Apr 28, 2009
Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC44 citations96
US7521041B2Apr 21, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC27 citations96
US7491736B2Feb 17, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations96
US7262205B2Aug 28, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC50 citations96
US7687521B2Mar 30, 2010
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC23 citations93
US7683173B2Mar 23, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC23 citations93
US7629336B2Dec 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations93
US7501442B2Mar 10, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC40 citations93
US7479562B2Jan 20, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC39 citations93
US7879879B2Feb 1, 2011
Biphenyl derivatives
THERAVANCE INC19 citations92
US7851631B2Dec 14, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC15 citations92
US7728144B2Jun 1, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC20 citations92
US8017617B2Sep 13, 2011
Amidine-containing compounds useful as muscarinic receptor antagonists
THERAVANCE INC7 citations84
US7868175B2Jan 11, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC11 citations84
US7851632B2Dec 14, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC14 citations84
US7834185B2Nov 16, 2010
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC8 citations84
US7285564B2Oct 23, 2007
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
THERAVANCE INC10 citations84
US7960385B2Jun 14, 2011
Guanidine-containing compounds useful as muscarinic receptor antagonists
THERAVANCE INC6 citations74
US7368463B2May 6, 2008
Substituted 4-amino-1-benzylpiperidine compounds
THERAVANCE INC7 citations74
US7250414B2Jul 31, 2007
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC7 citations74
US8378121B2Feb 19, 2013
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC1 citations63
US8039489B2Oct 18, 2011
Guanidine-containing compounds useful as muscarinic receptor antagonists
THERAVANCE INC3 citations63
MAMMEN MATHAI
8 patentsUS8273894B2Sep 25, 2012
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI15 citations96
US8173815B2May 8, 2012
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI15 citations96
US9452161B2Sep 27, 2016
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI11 citations92
US9283183B2Mar 15, 2016
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI12 citations92
US8912334B2Dec 16, 2014
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI13 citations92
US8557997B2Oct 15, 2013
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI13 citations92
US8067439B2Nov 29, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI8 citations84
US8618131B2Dec 31, 2013
Biphenyl derivatives
MAMMEN MATHAI3 citations74
THERAVANCE BIOPHARMA R&D IP LLC
6 patentsUS11247969B2Feb 15, 2022
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC6 citations94
US10570092B2Feb 25, 2020
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC8 citations93
US10343995B2Jul 9, 2019
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US10106503B2Oct 23, 2018
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US9926272B2Mar 27, 2018
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US12258316B2Mar 25, 2025
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC0 citations73
CONCENTRIC ANALGESICS INC
2 patentsCOLSON PIERRE-JEAN
1 patentJI YUHUA
1 patentShowing the top 50 of 71 patents by PatentIndex Score.